{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:45Z","timestamp":1783075905426,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40266-020-00784-9","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T06:03:41Z","timestamp":1595225021000},"page":"691-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of Antidepressants in Older People during a 10-Year Period: An Observational Study on Prescribed Doses and Serum Levels"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-6562","authenticated-orcid":false,"given":"Kristine","family":"Tveit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0720-1780","authenticated-orcid":false,"given":"Ragnhild Birkeland","family":"Waade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Miodini","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-1680","authenticated-orcid":false,"given":"Susanna M.","family":"Wallerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"20","key":"784_CR1","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.2017.5706","volume":"317","author":"RM Kok","year":"2017","unstructured":"Kok RM, Reynolds CF. Management of depression in older adults: a review. JAMA. 2017;317(20):2114\u2013222.","journal-title":"JAMA"},{"key":"784_CR2","unstructured":"Norwegian Prescription Database. Norwegian Institute of Public Health. 2019. https:\/\/www.reseptregisteret.no\/. Accessed 25 Sep 2019."},{"key":"784_CR3","unstructured":"Drug Consumption in Norway 2012\u20132016. Norwegian Institute of Public Health. 2017. https:\/\/www.fhi.no\/contentassets\/0a8afbeb4c904d14b7b8a773bc25766e\/legemiddelforbruket-2012-2016.pdf. Accessed 15 Mar 2017."},{"issue":"4","key":"784_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/ageing\/afm056","volume":"36","author":"DG Hansen","year":"2007","unstructured":"Hansen DG, Rosholm J-U, Gichangi A, Vach W. Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing. 2007;36(4):449\u201354.","journal-title":"Age Ageing"},{"key":"784_CR5","unstructured":"Health at a Glance 2019. OECD. 2019. https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/health-at-a-glance-2019_4dd50c09-en. Accessed 4 Jun 2020."},{"key":"784_CR6","unstructured":"Winerman L. By the numbers: Antidepressant use on the rise. In: Monitor on Psychology. American Psychological Association. 2017. https:\/\/www.apa.org\/monitor\/2017\/11\/numbers. Accessed 4 Jun 2020."},{"issue":"5","key":"784_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002512-200926050-00002","volume":"26","author":"A Darowski","year":"2009","unstructured":"Darowski A, Chambers SA, Chambers DJ. Antidepressants and falls in the elderly. Drugs Aging. 2009;26(5):381\u201394. https:\/\/doi.org\/10.2165\/00002512-200926050-00002.","journal-title":"Drugs Aging"},{"issue":"1","key":"784_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.ajkd.2016.08.020","volume":"69","author":"S Gandhi","year":"2017","unstructured":"Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG, et al. Second-generation antidepressants and hyponatremia risk: a population-based cohort study of older adults. Am J Kidney Dis. 2017;69(1):87\u201396.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"784_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1574886313666180605095130","volume":"13","author":"J Read","year":"2018","unstructured":"Read J, Williams J. Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects. Curr Drug Saf. 2018;13(3):176\u201386. https:\/\/doi.org\/10.2174\/1574886313666180605095130.","journal-title":"Curr Drug Saf"},{"issue":"1","key":"784_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"784_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.12596","volume":"80","author":"EA Davies","year":"2015","unstructured":"Davies EA, O'Mahony MS. Adverse drug reactions in special populations\u2013the elderly. Br J Clin Pharmacol. 2015;80(4):796\u2013807.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"784_CR12","first-page":"1","volume":"28","author":"M \u0106urkovi\u0107","year":"2016","unstructured":"\u0106urkovi\u0107 M, Dodig-\u0106urkovi\u0107 K, Petek Eri\u0107 A, Kralik K, Pivac N. Psychotropic medications in older adults: a review. Psychiatria Danubina. 2016;28(1):1\u201324.","journal-title":"Psychiatria Danubina"},{"issue":"2","key":"784_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"issue":"1","key":"784_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/11598420-000000000-00000","volume":"29","author":"KD Hill","year":"2012","unstructured":"Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging. 2012;29(1):15\u201330. https:\/\/doi.org\/10.2165\/11598420-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"10","key":"784_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","volume":"30","author":"K Johnell","year":"2007","unstructured":"Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30(10):911\u20138. https:\/\/doi.org\/10.2165\/00002018-200730100-00009.","journal-title":"Drug Saf"},{"issue":"6","key":"784_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/11631760-000000000-00000","volume":"29","author":"M Petrovic","year":"2012","unstructured":"Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29(6):453\u201362. https:\/\/doi.org\/10.2165\/11631760-000000000-00000.","journal-title":"Drugs Aging"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mad.2019.04.005","volume":"180","author":"K Rockwood","year":"2019","unstructured":"Rockwood K, Howlett SE. Age-related deficit accumulation and the diseases of ageing. Mech Ageing Dev. 2019;180:107\u201316. https:\/\/doi.org\/10.1016\/j.mad.2019.04.005.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"784_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/FTD.0b013e318241dce0","volume":"34","author":"RB Waade","year":"2012","unstructured":"Waade RB, Molden E, Refsum H, Hermann M. Serum concentrations of antidepressants in the elderly. Ther Drug Monit. 2012;34(1):25\u201330.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"784_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00228-014-1696-8","volume":"70","author":"RB Waade","year":"2014","unstructured":"Waade RB, Hermann M, Moe HL, Molden E. Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups. Eur J Clin Pharmacol. 2014;70(8):933\u201340. https:\/\/doi.org\/10.1007\/s00228-014-1696-8.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"784_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/bcpt.12796","volume":"121","author":"MR Hansen","year":"2017","unstructured":"Hansen MR, Kuhlmann IB, Potteg\u00e5rd A, Damkier P. Therapeutic drug monitoring of venlafaxine in an everyday clinical setting: analysis of age, sex and dose concentration relationships. Basic Clin Pharmacol Toxicol. 2017;121(4):298\u2013302.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"784_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00702-014-1317-9","volume":"122","author":"HP Sigurdsson","year":"2015","unstructured":"Sigurdsson HP, Hefner G, Ben-Omar N, K\u00f6stlbacher A, Wenzel-Seifert K, Hiemke C, et al. Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI. J Neural Transm. 2015;122(5):721\u20139.","journal-title":"J Neural Transm."},{"issue":"4","key":"784_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/FTD.0000000000000169","volume":"37","author":"M Hermann","year":"2015","unstructured":"Hermann M, Waade RB, Molden E. Therapeutic drug monitoring of selective serotonin reuptake inhibitors in elderly patients. Ther Drug Monit. 2015;37(4):546\u20139. https:\/\/doi.org\/10.1097\/FTD.0000000000000169.","journal-title":"Ther Drug Monit"},{"key":"784_CR23","unstructured":"The Norwegian Patient Safety Programme: In Safe Hands. Norwegian Ministry of Health Care Services. 2016. https:\/\/www.pasientsikkerhetsprogrammet.no\/om-oss\/english\/the-norwegian-patient-safety-programme-in-safe-hands. Accessed 25 Sep 2019."},{"key":"784_CR24","unstructured":"Safety concerns: Citalopram\u2014Risk of QT interval prolongation. In: Monthly report: 1110. European Medicines Agency. 2011. https:\/\/www.ema.europa.eu\/en\/documents\/report\/monthly-report-pharmacovigilance-working-party-phvwp-october-2011-plenary-meeting_en.pdf. Accessed 15 Mar 2019."},{"key":"784_CR25","unstructured":"Safety concerns: Escitalopram\u2014Risk of QT interval prolongation. In: Monthly report: 1111. European Medicines Agency. 2011. https:\/\/www.ema.europa.eu\/en\/documents\/report\/monthly-report-pharmacovigilance-working-party-phvwp-november-2011-plenary-meeting_en.pdf. Accessed 15 Mar 2019."},{"issue":"01\/02","key":"784_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(01\/02):9\u201362.","journal-title":"Pharmacopsychiatry"},{"issue":"01","key":"784_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0031-1286346","volume":"45","author":"S Unterecker","year":"2012","unstructured":"Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication\u2013a case report. Pharmacopsychiatry. 2012;45(01):30\u20134.","journal-title":"Pharmacopsychiatry"},{"key":"784_CR28","unstructured":"Mirtazapine 15 mg orodispersible tablets. EMC. 2019. https:\/\/www.medicines.org.uk\/emc\/product\/4750\/smpc. Accessed 15 Mar 2019."},{"key":"784_CR29","first-page":"CD006528","volume":"12","author":"N Watanabe","year":"2011","unstructured":"Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011;12:CD006528.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"784_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1060028018794005","volume":"53","author":"AL Bixby","year":"2019","unstructured":"Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2019;53(2):186\u201394.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"784_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","volume":"17","author":"DF Ionescu","year":"2015","unstructured":"Ionescu DF, Rosenbaum JF, Alpert JE. Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci. 2015;17(2):111.","journal-title":"Dialogues Clin Neurosci"},{"key":"784_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/164_2018_164","volume":"250","author":"RC Shelton","year":"2019","unstructured":"Shelton RC. Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol. 2019;250:145\u201380. https:\/\/doi.org\/10.1007\/164_2018_164.","journal-title":"Handb Exp Pharmacol"},{"issue":"01","key":"784_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-0044-102009","volume":"52","author":"G Hefner","year":"2019","unstructured":"Hefner G, Hahn M, Hohner M, Roll SC, Klimke A, Hiemke C. QTC time correlates with amitriptyline and venlafaxine serum levels in elderly psychiatric inpatients. Pharmacopsychiatry. 2019;52(01):38\u2013433.","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"784_CR34","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1038\/tp.2016.104","volume":"6","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Nilsson S, Eriksson E. A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Transl Psychiatry. 2016;6(6):e834. https:\/\/doi.org\/10.1038\/tp.2016.104.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"784_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/s2215-0366(19)30217-2","volume":"6","author":"TA Furukawa","year":"2019","unstructured":"Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry. 2019;6(7):601\u20139. https:\/\/doi.org\/10.1016\/s2215-0366(19)30217-2.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"784_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/JCP.0b013e318218f503","volume":"31","author":"EO Haji","year":"2011","unstructured":"Haji EO, Tadic A, Wagner S, Dragicevic A, M\u00fcller MJ, Boland K, et al. Association between citalopram serum levels and clinical improvement of patients with major depression. J Clin Psychopharmacol. 2011;31(3):281\u20136.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"784_CR37","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.euroneuro.2017.06.009","volume":"27","author":"V Florio","year":"2017","unstructured":"Florio V, Porcelli S, Saria A, Serretti A, Conca A. Escitalopram plasma levels and antidepressant response. Eur Neuropsychopharmacol. 2017;27(9):940\u20134.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"784_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1176\/appi.ajp.2017.17050550","volume":"175","author":"MM Juki\u0107","year":"2018","unstructured":"Juki\u0107 MM, Haslemo T, Molden E, Ingelman-Sundberg M. Impact of CYP2C19 genotype on escitalopram exposure and therapeutic failure: a retrospective study based on 2,087 patients. Am J Psychiatry. 2018;175(5):463\u201370.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"784_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.0306-5251.2001.01401.x","volume":"51","author":"I Barat","year":"2001","unstructured":"Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51(6):615\u201322. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.01401.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"784_CR40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00228-014-1720-z","volume":"70","author":"M Tveito","year":"2014","unstructured":"Tveito M, Bramness JG, Engedal K, Lorentzen B, Refsum H, Hoiseth G. Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations. Eur J Clin Pharmacol. 2014;70(9):1139\u201345. https:\/\/doi.org\/10.1007\/s00228-014-1720-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"784_CR41","doi-asserted-by":"publisher","first-page":"e12981","DOI":"10.1111\/ctr.12981","volume":"31","author":"EA Leven","year":"2017","unstructured":"Leven EA, Annunziato R, Helcer J, Lieber SR, Knight CS, Wlodarkiewicz C, et al. Medication adherence and rejection rates in older vs younger adult liver transplant recipients. Clin Transplant. 2017;31(6):e12981.","journal-title":"Clin Transplant"},{"issue":"10","key":"784_CR42","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.clinthera.2018.08.012","volume":"40","author":"JT Range","year":"2018","unstructured":"Range JT, LaFontaine PR, Ryder PT, Polston M. Factors associated with adherence to statin medications of patients enrolled in a self-insured university health plan. Clin Ther. 2018;40(10):1692\u2013700. https:\/\/doi.org\/10.1016\/j.clinthera.2018.08.012.","journal-title":"Clin Ther"},{"issue":"4","key":"784_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","volume":"31","author":"L Pasina","year":"2014","unstructured":"Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31(4):283\u20139. https:\/\/doi.org\/10.1007\/s40266-014-0163-7.","journal-title":"Drugs Aging"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00784-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:19:56Z","timestamp":1626736796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00784-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00784-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"20 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors own institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Kristine Tveit, Monica Hermann, Ragnhild Birkeland Waade, Roy Miodini Nilsen, Susanna M. Wallerstedt and Espen Molden declare they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Regional Committee for Medical and Health Research Ethics (ref. 2018\/655) and the Hospital Investigational Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Ethical approval was granted without the collection of informed consent from participants. This was based on the evaluation of risk\u2013benefit and also practical reasons (historical data from more than 17,000 individuals). To protect confidentiality, personal identifiers were not included in the dataset.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}